NCT05526430View on ClinicalTrials.gov

Study of Harmine in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

June 23, 2023

Study Completion Date

June 23, 2023

Conditions
Diabetes Mellitus
Interventions
DRUG

Harmine Hydrochloride Capsules

capsules taken orally

Trial Locations (1)

10029

Depression and Anxiety Center, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

James Murrough

OTHER